medigraphic.com
SPANISH

Revista Mexicana de Patología Clínica y Medicina de Laboratorio

ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 1

<< Back

Rev Mex Patol Clin Med Lab 2005; 52 (1)

Results on the gray zone from the sift for HIV and CHV may indicate immediate seroconversion

Aguirre GGE, Martínez AJC, Arenas EIA
Full text How to cite this article

Language: Spanish
References: 11
Page: 63-68
PDF size: 44.39 Kb.


Key words:

Gray zone, antibodies anti-HCV, antibodies anti-HIV, donation of blood.

ABSTRACT

Objective: To determine if the results from the sift for HIV1/HIV2, that usually fall into the gray zone, may indicate immediate seroconversion. Materials and methods: At the blood bank of National Medical Center XXI Century (Centro Médico Nacional Siglo XXI), we performed a study to determine the aim established above. The research went from May 2002 to January 2003. During this period, 43,669 blood donors were received. From them, 72 obtained repeat results on the gray zone; therefore, they were applied a confirmation test. The sift was repeated in forty of the 72 donors between three and nine months after the donation; applying a confirmation test to those ones presenting results on the gray zone or being reactive. Results: Twenty-two donors with HCV results on the gray zone were taken a second blood sample; ten of them repeated the results on the gray zone, but two of them passed from negative confirmation to indeterminate confirmation in the second sample. Twelve donors presenting HIV on the gray zone were taken a second sample; only three of them were practiced a second confirmative test. The rest presented a sift completely negative. Conclusions: It is necessary to perform deeper studies to determine if there is a relationship between gray zone and seroconversion.


REFERENCES

  1. Barbara JAJ. Prevention of infections transmissible by blood derivatives. Transf Sci 1998; 19: 3-7.

  2. Barbara JAJ. Microbiological safety of blood transfusion. Vox Sang 1998; 74 (suppl 2): 11-13.

  3. Müller-Breitkreutz K. Results of viral marker screening of unpaid blood donations and probability of window period donations in 1997. Vox Sang 2000; 78: 149-157.

  4. Kleinman S, Busch MJ, Korelitz JJ, Schreiiber GB. The incidence/window period model and its use to assess the risk of transfusion –transmitted human immunodeficiency virus and hepatitis C virus infection. Trans Med Rev 1997; 11: 155-172.

  5. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 1685-1690.

  6. Loubiére S, Rotily M, Durand-Zaleskii, Costagliola D. Including polymerase chain reaction in screening for hepatitis C virus RNA in blood donations is not cost-effective. Vox Sang 2001; 80: 199-204.

  7. Busch MP, Lee L, Satten GA et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35: 91-97.

  8. NOM para la prevención y control de la infección por virus de la inmunodeficiencia humana 1993 (NOM-010-SSA2-1993).

  9. NOM para la disposición de sangre humana y sus componentes con fines terapéuticos 1993 (NOM-003-SSA2-1993). Diario Oficial de la Nación 1994: 18: 77-82.

  10. Manual del operador del equipo Abbott-Prism. 1998.

  11. Manual del operador del equipo Abbott-Axsym. 1996.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Patol Clin Med Lab. 2005;52